PortfoliosLab logoPortfoliosLab logo
CURE vs. TQQQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CURE vs. TQQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares UltraPro QQQ (TQQQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -18.38% return, which is significantly lower than TQQQ's 64.46% return. Over the past 10 years, CURE has underperformed TQQQ with an annualized return of 11.65%, while TQQQ has yielded a comparatively higher 45.33% annualized return.


CURE

1D
2.17%
1M
4.39%
YTD
-18.38%
6M
-18.70%
1Y
21.60%
3Y*
-0.15%
5Y*
0.21%
10Y*
11.65%

TQQQ

1D
-0.76%
1M
33.35%
YTD
64.46%
6M
55.93%
1Y
137.89%
3Y*
69.49%
5Y*
28.37%
10Y*
45.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. TQQQ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
-18.38%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%
TQQQ
ProShares UltraPro QQQ
64.46%34.35%58.27%198.04%-79.09%82.98%110.05%133.84%-19.79%118.06%

Correlation

The correlation between CURE and TQQQ is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.44

Correlation (10Y)
Calculated over the trailing 10-year period

0.54

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2011

0.59

Over the past year, the correlation between CURE and TQQQ has dropped to 0.17 - well below their long-term average of 0.59, suggesting their price drivers have been diverging.

CURE vs. TQQQ - Sectors Allocation Comparison


Sectors
CURE
TQQQ

Healthcare

100.0%
4.2%

Basic Materials

-

1.1%

Communication Services

-

15.8%

Consumer Cyclical

-

12.3%

Consumer Defensive

-

7.7%

Energy

-

0.6%

Financial Services

-

0.2%

Industrials

-

2.8%

Real Estate

-

0.1%

Technology

-

53.8%

Utilities

-

1.4%

Healthcare

CURE
100.0%
TQQQ
4.2%

Basic Materials

CURE

-

TQQQ
1.1%

Communication Services

CURE

-

TQQQ
15.8%

Consumer Cyclical

CURE

-

TQQQ
12.3%

Consumer Defensive

CURE

-

TQQQ
7.7%

Energy

CURE

-

TQQQ
0.6%

Financial Services

CURE

-

TQQQ
0.2%

Industrials

CURE

-

TQQQ
2.8%

Real Estate

CURE

-

TQQQ
0.1%

Technology

CURE

-

TQQQ
53.8%

Utilities

CURE

-

TQQQ
1.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CURE vs. TQQQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE
CURE Risk / Return Rank: 1818
Overall Rank
CURE Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 1919
Sortino Ratio Rank
CURE Omega Ratio Rank: 1818
Omega Ratio Rank
CURE Calmar Ratio Rank: 1717
Calmar Ratio Rank
CURE Martin Ratio Rank: 1717
Martin Ratio Rank

TQQQ
TQQQ Risk / Return Rank: 7171
Overall Rank
TQQQ Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
TQQQ Sortino Ratio Rank: 6565
Sortino Ratio Rank
TQQQ Omega Ratio Rank: 6565
Omega Ratio Rank
TQQQ Calmar Ratio Rank: 7373
Calmar Ratio Rank
TQQQ Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. TQQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares UltraPro QQQ (TQQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CURETQQQDifference
Sharpe ratioReturn per unit of total volatility

-2.41

Sortino ratioReturn per unit of downside risk

-2.05

Omega ratioGain probability vs. loss probability

1.12

1.40

-0.29

Calmar ratioReturn relative to maximum drawdown

0.70

3.75

-3.05

Martin ratioReturn relative to average drawdown

1.61

12.27

-10.66

CURE vs. TQQQ - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.50, which is lower than the TQQQ Sharpe Ratio of 2.92. The chart below compares the historical Sharpe Ratios of CURE and TQQQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CURETQQQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.50

2.92

-2.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.00

0.43

-0.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.24

0.69

-0.45

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

0.74

-0.28

Drawdowns

CURE vs. TQQQ - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum TQQQ drawdown of -81.66%. Use the drawdown chart below to compare losses from any high point for CURE and TQQQ.


Loading charts...

Drawdown Indicators


CURETQQQDifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-81.66%

+12.47%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-36.97%

+5.87%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-58.04%

+6.11%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-81.66%

+29.43%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

-81.66%

+12.47%

Current Drawdown

Current decline from peak

-35.21%

-0.76%

-34.45%

Average Drawdown

Average peak-to-trough decline

-18.15%

-18.52%

+0.37%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.43%

11.28%

+2.15%

Volatility

CURE vs. TQQQ - Volatility Comparison

The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 11.99%, while ProShares UltraPro QQQ (TQQQ) has a volatility of 13.29%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than TQQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CURETQQQDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.99%

13.29%

-1.30%

Volatility (6M)

Calculated over the trailing 6-month period

29.83%

36.04%

-6.21%

Volatility (1Y)

Calculated over the trailing 1-year period

43.19%

47.60%

-4.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.69%

66.53%

-22.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.51%

65.96%

-16.45%

CURE vs. TQQQ - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than TQQQ's 0.95% expense ratio.


Dividends

CURE vs. TQQQ - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.31%, more than TQQQ's 0.36% yield.


PositionTTM20252024202320222021202020192018201720162015
CURE
Direxion Daily Healthcare Bull 3x Shares
1.31%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%
TQQQ
ProShares UltraPro QQQ
0.36%0.65%1.27%1.26%0.57%0.00%0.00%0.06%0.11%0.00%0.00%0.01%

Frequently Asked Questions


CURE and TQQQ have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TQQQ has higher volatility (13.29%) compared to CURE (11.99%). In terms of maximum drawdown, CURE dropped -69.19% vs TQQQ's -81.66%.

On 10-year performance, TQQQ leads with 45.33% vs 11.65% for CURE. On fees, TQQQ is cheaper at 0.95% per year. On volatility, CURE has been the lower-risk option at 11.99%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, TQQQ has performed better with a 45.33% return vs 11.65%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

TQQQ is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.31%, compared with 0.36% for TQQQ.

CURE tracks Health Care Select Sector Index (300%), while TQQQ tracks NASDAQ-100 Index (300%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 1.08% for CURE and 0.95% for TQQQ.

TQQQ currently has the higher Sharpe Ratio (2.92 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and TQQQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer